Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma

BMC Cancer
Ming-Chun MaYen-Yang Chen

Abstract

Post-surgical prognosis is usually poor for combined hepatocellular cholangiocarcinoma (CHCC-CC), a rare primary liver cancer. Although midkine (MK) is a prognostic biomarker for several known cancers, it is not known whether it can be used as such in resectable CHCC-CC. This study examined whether MK expression can predict recurrence and survival in patients with resectable CHCC-CC. We retrospectively enrolled 52 patients with resectable CHCC-CC who had received curative hepatic resections. MK expression was assessed in post-surgical immunohistochemical studies of specimens in paraffin blocks. Clinical outcomes were analyzed from medical records. Two-year disease-free and three-year overall survival rates were 42.1% and 44.6%. MK was expressed in 30 patients. Univariate analysis showed patients positively expressing MK had a significantly poorer 2-year disease free and three-year overall survival. Multivariate analysis found positive MK expression independently predicted recurrence. Positive expression of MK predicts poor prognosis in patients with resectable CHCC-CC.

References

Aug 1, 1996·Journal of Gastroenterology and Hepatology·J TaguchiM Kojiro
Sep 16, 1998·Journal of Gastroenterology and Hepatology·I O NgL T Ma
Aug 10, 2002·The American Journal of Surgical Pathology·Satish K TickooDavid S Klimstra
Jan 7, 2003·Archives of Surgery·Chi-Leung LiuJohn Wong
Aug 13, 2003·Japanese Journal of Clinical Oncology·Yoshiko YanoMasatoshi Makuuchi
Jan 14, 2005·International Journal of Clinical Practice·C H TohK K Ng
Jan 15, 2005·Cancer Science·Yuki ObataUNKNOWN Tokyo Research Group on Prevention of Gastric Cancer
Jun 28, 2005·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Yuichi SanadaYoshiyuki Yamaguchi
Apr 13, 2006·World Journal of Gastroenterology : WJG·Ying-Jia Ren, Qing-Yun Zhang
Apr 9, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mina KomutaTania Roskams
Apr 22, 2008·Cancer Science·Kojiro TanabeNobuo Yaegashi
Dec 9, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Hiroharu TakenakaKenji Kadomatsu
Jun 23, 2009·Cancer Science·Mutsuko IbusukiYukio Ando
Aug 18, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Augusto VillanuevaJosep M Llovet
Jun 12, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Xiong CaiMengchao Wu
Jun 26, 2012·Pathology International·Kazuma Sakamoto, Kenji Kadomatsu
Apr 30, 2013·Journal of Biochemistry·Kenji KadomatsuShoma Tsubota
May 31, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wen-Wei ZhuQing-Hai Ye
Oct 30, 2013·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Tai-Jan ChiuHock-Liew Eng
Jan 28, 2014·British Journal of Pharmacology·Takashi Muramatsu, Kenji Kadomatsu
Feb 26, 2014·Molecular Cancer Research : MCR·Tamina RawnaqCenap Güngör
Dec 6, 2014·Hepatobiliary & Pancreatic Diseases International : HBPD INT·Seung Duk LeeEun Kyung Hong
Jul 2, 2015·Annals of Surgical Treatment and Research·Ryounggo KimGibong Chae
Jul 15, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Fuguang LiChangyuan Kou
Dec 3, 2015·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Young-In YoonSung-Gyu Lee

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
antibody assay

Software Mentioned

SPSS

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.